Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

Historical Holders from Q3 2021 to Q3 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
TNYA on Nasdaq
Shares outstanding
213,478,610
Price per share
$1.62
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
34,529,364
Holdings value
$55,547,746
% of all portfolios
0%
Share change
+2,998,917
Value change
+$5,329,372
Average buys %
+0%
Average sells %
-0%
Number of holders
89
Price from insider filings
$1.33
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
COLUMN GROUP III, LP 23% -24% $67,066,440 49,313,559 0% The Column Group Opportunity III, LP 15 Dec 2025
Woodline Partners LP 5% -26% $6,120,000 +$2,097,006 9,000,000 +52% Woodline Partners LP 30 Jun 2025
Empery Asset Management, LP 5% -50% $5,641,468 -$293,106 8,296,276 -4.9% Empery Asset Management, LP 30 Jun 2025
Casdin Capital, LLC 4.3% $3,231,826 6,732,971 Casdin Capital, LLC 04 Mar 2025
BlackRock, Inc. 1.7% -71% $1,670,287 -$1,566,919 2,732,800 -48% BlackRock, Inc. 30 Jun 2025
JPMORGAN CHASE & CO 2.8% -53% $1,096,279 -$1,378,097 2,283,914 -56% JPMORGAN CHASE & CO. 28 Feb 2025
As of 30 Sep 2025, Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) has 89 institutional shareholders filing 13F forms. They hold 34,529,364 shares of 213,478,610 outstanding shares (16%) .

Top 25 institutional shareholders own 15% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
Column Group LLC 4.4% 9,400,290 0% 18% $14,852,458
VANGUARD GROUP INC 2.4% 5,064,857 +6.5% 0% $8,205,068
MILLENNIUM MANAGEMENT LLC 2.1% 4,504,592 +562% 0.01% $7,297,439
BlackRock, Inc. 1.1% 2,327,201 -15% 0% $3,770,066
RENAISSANCE TECHNOLOGIES LLC 0.79% 1,678,202 -9% 0% $2,718,687
GEODE CAPITAL MANAGEMENT, LLC 0.55% 1,175,535 -4.5% 0% $1,905,190
Euclidean Capital LLC 0.48% 1,015,705 0% 0.69% $1,645,442
Alphabet Inc. 0.43% 915,705 0% 0.06% $1,483,442
TWO SIGMA INVESTMENTS, LP 0.43% 910,568 +92% 0% $1,475,120
Aberdeen Group plc 0.28% 600,700 0% 0% $973,134
Schonfeld Strategic Advisors LLC 0.22% 465,957 0.01% $754,849
StepStone Group LP 0.22% 462,163 0% 0.37% $748,704
GSA CAPITAL PARTNERS LLP 0.22% 461,804 0.06% $748,000
STATE STREET CORP 0.21% 445,821 +112% 0% $722,230
Casdin Capital, LLC 0.17% 361,969 0% 0.05% $586,390
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.17% 354,739 +15% 0% $574,677
Raiffeisen Bank International AG 0.16% 350,000 0.01% $553,000
DIADEMA PARTNERS LP 0.15% 315,519 0.36% $511,141
Marex Group plc 0.14% 302,500 -27% 0.01% $490,050
Trustees of Columbia University in the City of New York 0.14% 291,828 0% 0.07% $472,761
ROYAL BANK OF CANADA 0.12% 264,100 -10% 0% $428,000
NORTHERN TRUST CORP 0.11% 239,489 +85% 0% $387,972
GOLDMAN SACHS GROUP INC 0.11% 227,497 -19% 0% $368,545
TWO SIGMA ADVISERS, LP 0.1% 213,500 +27% 0% $345,870
UBS Group AG 0.09% 196,727 +64% 0% $318,698

Institutional Holders of Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 34,529,364 $55,547,746 +$5,329,372 $1.62 89
2025 Q2 31,571,002 $19,291,816 -$9,941,570 $0.6112 87
2025 Q1 48,166,604 $27,453,207 +$1,982,469 $0.5701 104
2024 Q4 43,606,618 $62,359,118 -$25,849,595 $1.43 83
2024 Q3 57,630,896 $111,228,656 +$67,017 $1.93 91
2024 Q2 57,076,933 $176,981,415 +$2,253,617 $3.10 94
2024 Q1 56,023,483 $292,935,438 +$51,188,426 $5.23 89
2023 Q4 46,629,309 $151,075,893 -$9,232,276 $3.24 73
2023 Q3 49,741,215 $126,838,955 -$3,313,935 $2.55 77
2023 Q2 47,651,950 $279,717,125 +$15,890,634 $5.87 79
2023 Q1 45,028,141 $128,326,772 -$2,290,501 $2.85 65
2022 Q4 47,128,809 $94,724,321 +$22,977,493 $2.01 67
2022 Q3 35,221,703 $102,151,001 -$12,249,474 $2.90 67
2022 Q2 37,062,342 $208,638,443 -$1,855,716 $5.63 47
2022 Q1 37,349,150 $439,920,087 +$23,331,598 $11.78 50
2021 Q4 35,354,543 $667,600,957 +$18,069,398 $18.95 46
2021 Q3 24,450,664 $499,284,447 +$499,284,447 $20.65 44